`
`
`
`
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`
`
`IN RE: SITAGLIPTIN PHOSPHATE (’708
`& ’921) PATENT LITIGATION
`
`
`
`
`
`
`
`
`
`
`
`MDL No. 19-2902-RGA
`
`
`
`
`
`
`
`C.A. No. 19-1489-RGA
`
`
`
`
`MERCK SHARP & DOHME CORP.,
`
`
`
`
`Plaintiff,
`
`v.
`
`
`
`
`MYLAN PHARMACEUTICALS INC.,
`
`
`
`
`
`
`Defendant.
`
`
`JOINT STIPULATION AND [PROPOSED] ORDER
`CONCERNING ADMISSIBILITY OF EVIDENCE
`
`
`
`ME1 35245398v.1
`
`
`
`Case 1:19-cv-00101-TSK Document 94 Filed 09/16/21 Page 2 of 4 PageID #: 4806
`
`
`
`WHEREAS Plaintiff Merck Sharp & Dohme Corp. (“Merck”) filed a Notice of
`
`Deposition seeking to take the deposition of Abhijit Deshmukh pursuant to Federal Rule of Civil
`
`Procedure 30(b)(1);
`
`WHEREAS, counsel for the parties met and conferred regarding Merck’s 30(b)(1) Notice
`
`of Deposition of Abhijit Deshmukh; and
`
`WHEREAS, Merck agreed to forgo the deposition of Abhijit Deshmukh if Defendant
`
`Mylan Pharmaceuticals Inc. (“Mylan”) agreed to stipulate to the authenticity and admissibility of
`
`certain of Mylan’s Lab Notebooks (bates numbers identified below);
`
`Merck and Defendant Mylan Pharmaceuticals Inc. (“Mylan”) hereby STIPULATE, and
`
`request that the court ORDER, as follows:
`
`1.
`
`Mylan’s Lab Notebooks—Bates Nos. MYLAN_0104154-283;
`
`MYLAN_0104492-699; MYLAN_0104700-910; MYLAN_0111691-831; MYLAN_0105832-
`
`912; MYLAN_0109139-292—are authentic under Federal Rule of Evidence 901, and no
`
`additional foundation needs to be laid for the above documents to be admitted into evidence.
`
`Mylan will not object to the authenticity of the above documents or the admissibility of the
`
`above documents for any other reason, including on hearsay grounds, if they are offered as
`
`evidence at trial. Other than to admissibility, all other objections as to the use of the documents,
`
`once admitted, are reserved.
`
`2.
`
`This Stipulation regarding the above-referenced documents is only applicable to
`
`the above-captioned proceedings and to Case No. 1:19-cv-101-IMK (N.D.W. Va.), and may not
`
`be used in any other litigation against any party.
`
`
`Dated: December 15, 2020
`
`
`
`ME1 35245398v.1
`
`
`
`1
`
`
`
`Case 1:19-cv-00101-TSK Document 94 Filed 09/16/21 Page 3 of 4 PageID #: 4807
`
`
`
`
`
`
`
`MORRIS JAMES LLP
`
`/s/ Kenneth L. Dorsney
`Kenneth L. Dorsney (#3726)
`500 Delaware Avenue, Suite 1500
`Wilmington, DE 19801
`(302) 888-6800
`kdorsney@morrisjames.com
`
`OF COUNSEL:
`
`Deepro R. Mukerjee
`Lance Soderstrom
`KATTEN MUCHIN ROSENMAN LLP
`575 Madison Avenue
`New York, NY 10022
`(212) 940-8800
`Deepro.mukerjess@katten.com
`Lance.soderstrom@katten.com
`
`Jitendra Malik
`Alissa M. Pacchioli
`KATTEN MUCHIN ROSENMAN LLP
`550 South Tyron Street, Suite 2900
`Charlotte, NC 28202
`Jitty.malik@katten.com
`Alissa.pacchioli@katten.com
`
`Attorneys for Defendant
`Mylan Pharmaceuticals, Inc.
`
`
`
`
`
`
`
`
`
`
`MCCARTER & ENGLISH, LLP
`
`/s/ Alexandra M. Joyce
`Michael P. Kelly (#2295)
`Daniel M. Silver (#4758)
`Alexandra M. Joyce (#6423)
`Renaissance Centre
`405 N. King Street, 8th Floor
`Wilmington, DE 19801
`T: (302) 984-6300
`mkelly@mccarter.com
`dsilver@mccarter.com
`ajoyce@mccarter.com
`
`OF COUNSEL:
`
`Bruce R. Genderson
`Jessamyn S. Berniker
`Stanley E. Fisher
`Alexander S. Zolan
`Elise M. Baumgarten
`Shaun P. Mahaffy
`Anthony H. Sheh
`Jingyuan Luo
`Jihad Komis
`WILLIAMS & CONNOLLY LLP
`725 Twelfth Street, N.W.
`Washington, DC 20005
`T: (202) 434-5000
`F: (202) 434-5029
`bgenderson@wc.com
`jberniker@wc.com
`sfisher@wc.com
`azolan@wc.com
`ebaumgarten@wc.com
`smahaffy@wc.com
`asheh@wc.com
`jluo@wc.com
`jkomis@wc.com
`
`Attorneys for Plaintiff Merck Sharp & Dohme
`Corp.
`
`
`ME1 35245398v.1
`
`2
`
`
`
`Case 1:19-cv-00101-TSK Document 94 Filed 09/16/21 Page 4 of 4 PageID #: 4808
`
`
`
`
`
`
`
`
`
`IT IS SO ORDERED, this
`
`day of
`
`, 2020.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`UNITED STATES DISTRICT JUDGE
`
`ME1 35245398v.1
`
`3
`
`



